ArticleBioinformatics advances2026
Leveraging single-cell foundation models for accurate survival outcome prediction.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Foundation models trained on large-scale single-cell transcriptomes can capture rich molecular representations of cellular states, yet their potential for cancer survival prediction from bulk RNA-seq data remains largely unexplored. Results: We applied the single-cell foundation model scFoundation to derive patient-level embeddings across 25 cancer types from TCGA and systematically evaluated their prognostic value under both cancer-specific and pan-cancer settings. To leverage complementary information, we developed an Embedding-Gene-Survival Prediction (EGSP) model that integrates foundation model embeddings with gene expression and clinical variables. EGSP achieved a mean concordance index (C-index) of 0.724 across cancers and exceeded 0.8 in seven cancer types, consistently outperforming single-modality models and existing multi-omics survival approaches. Comparative analyses showed that embeddings derived from pretrained scFoundation weights exhibited lower redundancy with gene expression while retaining complementary prognostic signals relative to pan-cancer fine-tuned embeddings. Explainable AI analyses further revealed that prognostic embeddings capture interpretable biological programs related to tumor differentiation, immune activity, and tumor-intrinsic growth, enabling transparent survival prediction at both cohort and patient levels. Overall, single-cell foundation model embeddings provide biologically meaningful and partially non-redundant survival signals that substantially improve bulk RNA-seq-based prognostic modeling. Availability and implementation: https://github.com/weiliu123/EGSP.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.